Eton Pharmaceuticals, Inc.
NASDAQ:ETON
8.35 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 9.074 | 7.966 | 7.313 | 7.028 | 11.997 | 5.304 | 8.498 | 3.219 | 7.358 | 2.176 | 6.093 | 0.775 | 3.067 | 11.897 | 0.081 | -0.161 | 0.02 | 0.099 | 0.459 | 0 | 0 | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 3.448 | 2.959 | 3.683 | 2.625 | 2.315 | 1.958 | 2.138 | 1.201 | 2.745 | 0.718 | 0.28 | 0.617 | 0.136 | 1.59 | 0.3 | 0.144 | 0.028 | 0.102 | 0.453 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 5.626 | 5.007 | 3.63 | 4.403 | 9.682 | 3.346 | 6.36 | 2.018 | 4.613 | 1.458 | 5.813 | 0.158 | 2.931 | 10.307 | -0.219 | -0.305 | -0.008 | -0.003 | 0.006 | 0 | 0 | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.62 | 0.629 | 0.496 | 0.626 | 0.807 | 0.631 | 0.748 | 0.627 | 0.627 | 0.67 | 0.954 | 0.204 | 0.956 | 0.866 | -2.704 | 1.894 | -0.4 | -0.03 | 0.013 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 2.97 | 0.651 | 1.047 | 0.615 | 1.125 | 0.535 | 0.944 | 0.744 | 0.69 | 1.618 | 0.681 | 2.678 | 1.99 | 0.886 | 3.401 | 2.826 | 1.609 | 6.268 | 0.233 | 3.418 | 1.439 | 6.465 | 1.102 | 1.544 | 1.707 | 1.274 | 2.828 | 1.564 | 1.503 |
| General & Administrative Expenses
| 5.591 | 5.156 | 4.576 | 4.336 | 4.674 | 5.345 | 4.354 | 4.169 | 5.263 | 4.927 | 3.818 | 3.327 | 3.266 | 4.058 | 3.8 | 3.429 | 2.921 | 2.61 | 2.429 | 1.624 | 1.91 | 1.589 | 1.184 | 0.83 | 0.99 | 1.69 | 2.943 | 1.206 | 0.681 |
| Selling & Marketing Expenses
| 0 | 0 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 5.591 | 5.156 | 4.575 | 4.336 | 4.674 | 5.345 | 4.354 | 4.169 | 5.263 | 4.927 | 3.818 | 3.327 | 3.266 | 4.058 | 3.8 | 3.429 | 2.921 | 2.61 | 2.429 | 1.624 | 1.91 | 1.589 | 1.184 | 0.83 | 0.99 | 1.69 | 2.943 | 1.206 | 0.681 |
| Other Expenses
| 0 | 0 | -0.8 | 0 | 0.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.057 | -0.561 | -0.413 | -0.083 | 0 | -0.041 | 0 |
| Operating Expenses
| 8.561 | 5.807 | 5.622 | 4.951 | 5.799 | 5.88 | 5.298 | 4.913 | 5.953 | 6.545 | 4.499 | 6.005 | 5.256 | 4.944 | 7.201 | 6.255 | 4.53 | 8.878 | 2.662 | 5.042 | 3.349 | 8.054 | 2.286 | 2.374 | 2.697 | 2.964 | 5.792 | 2.77 | 2.184 |
| Operating Income
| -2.935 | -0.8 | -1.992 | -0.548 | 3.883 | -2.534 | 0.81 | -2.895 | -1.34 | -5.087 | 1.314 | -5.847 | -2.325 | 5.363 | -7.42 | -6.272 | -4.538 | -8.881 | -2.656 | -5.042 | -3.349 | -7.554 | -2.286 | -2.374 | -2.697 | -2.964 | -5.771 | -2.77 | -2.184 |
| Operating Income Ratio
| -0.323 | -0.1 | -0.272 | -0.078 | 0.324 | -0.478 | 0.095 | -0.899 | -0.182 | -2.338 | 0.216 | -7.545 | -0.758 | 0.451 | -91.605 | 38.957 | -226.9 | -89.707 | -5.786 | 0 | 0 | -15.108 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -0.052 | -0.011 | -0.017 | -0.031 | 0.8 | -0.126 | 0.102 | -0.15 | -0.218 | -0.243 | -0.275 | -0.247 | 0.546 | -0.247 | -0.267 | -0.232 | -0.192 | -0.168 | -0.04 | 0.077 | 0.1 | 0.144 | -1.526 | -0.561 | -0.413 | -0.083 | 0.023 | -0.041 | 0 |
| Income Before Tax
| -2.987 | -0.811 | -2.009 | -0.579 | 4.559 | -2.66 | 0.912 | -3.045 | -1.558 | -5.33 | 1.039 | -6.094 | -2.016 | 5.116 | -7.687 | -6.504 | -4.73 | -9.049 | -2.696 | -4.965 | -3.249 | -7.41 | -3.73 | -2.91 | -3.082 | -3.018 | -5.748 | -2.802 | -2.184 |
| Income Before Tax Ratio
| -0.329 | -0.102 | -0.275 | -0.082 | 0.38 | -0.502 | 0.107 | -0.946 | -0.212 | -2.449 | 0.171 | -7.863 | -0.657 | 0.43 | -94.901 | 40.398 | -236.5 | -91.404 | -5.874 | 0 | 0 | -14.82 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.054 | 0.209 | 0.247 | 0.242 | 0.713 | 0.252 | -0.102 | 0.15 | 0 | 0.243 | 0.275 | 0.004 | -0.309 | 0 | -0.161 | 0 | 0 | 0 | -0.148 | 0 | -0.123 | 0 | 1.444 | 0.729 | 0.385 | 0.054 | 1.443 | -0.009 | 0 |
| Net Income
| -3.041 | -0.811 | -2.256 | -0.579 | 4.559 | -2.912 | 0.912 | -3.195 | -1.558 | -5.573 | 1.039 | -6.094 | -2.016 | 5.116 | -7.687 | -6.504 | -4.73 | -9.049 | -2.696 | -4.965 | -3.249 | -7.41 | -3.73 | -2.91 | -3.082 | -3.018 | -7.191 | -2.802 | -2.275 |
| Net Income Ratio
| -0.335 | -0.102 | -0.308 | -0.082 | 0.38 | -0.549 | 0.107 | -0.993 | -0.212 | -2.561 | 0.171 | -7.863 | -0.657 | 0.43 | -94.901 | 40.398 | -236.5 | -91.404 | -5.874 | 0 | 0 | -14.82 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.12 | -0.032 | -0.088 | -0.023 | 0.18 | -0.11 | 0.04 | -0.13 | -0.062 | -0.22 | 0.04 | -0.24 | -0.08 | 0.21 | -0.32 | -0.31 | -0.23 | -0.5 | -0.15 | -0.28 | -0.18 | -0.42 | -0.32 | -0.52 | -0.55 | -0.54 | -2.01 | -0.5 | -0.69 |
| EPS Diluted
| -0.12 | -0.032 | -0.088 | -0.023 | 0.18 | -0.11 | 0.04 | -0.13 | -0.062 | -0.22 | 0.04 | -0.24 | -0.08 | 0.19 | -0.32 | -0.31 | -0.23 | -0.5 | -0.15 | -0.28 | -0.18 | -0.42 | -0.32 | -0.52 | -0.55 | -0.54 | -2.01 | -0.5 | -0.69 |
| EBITDA
| -2.656 | -0.548 | -1.717 | -0.346 | 4.683 | -2.321 | 1.062 | -2.725 | -0.169 | -4.906 | 1.314 | -5.762 | -2.786 | 5.518 | -7.42 | -6.108 | -4.374 | -8.719 | -2.656 | -4.921 | -3.349 | -7.499 | -0.737 | -1.813 | -2.271 | -2.871 | -5.755 | -2.729 | -0.091 |
| EBITDA Ratio
| -0.293 | -0.069 | -0.235 | -0.049 | 0.39 | -0.438 | 0.125 | -0.847 | -0.023 | -2.255 | 0.216 | -7.435 | -0.908 | 0.464 | -91.605 | 37.938 | -218.7 | -88.071 | -5.786 | 0 | 0 | -14.998 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |